Lp(a) and Residual Risks

Lp(a) and Risks of Atherosclerotic Cardiovascular Diseases in Patients with Coronary Artery Disease who Received Lowering LDL-C Levels - Lp(a) and Residual Risks

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050260016

Enrollment

2000

Registered

2026-04-09

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease Coronary Artery Disease, LDL-C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with CAD who required PCI

Exclusion criteria

Exclusion criteria: CAD attributable to non-atherosclerotic causes

Design outcomes

Primary

Measure	Time frame
The occurence of cardiovascular events	—

Secondary

Measure	Time frame
each component of MACE	—

Contacts

Public ContactYuko Yoshioka

National Cerebral & Cardiovascular Center

yoshioka.yuko@ncvc.go.jp+81-6-6170-1070

Outcome results